Fidelity Investments
IRON icon

Fidelity Investments’s Disc Medicine IRON Stock Holding History

Fidelity Investments’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357M Buy
5,586,894
+136,672
+3% +$9.48M 0.02% 636
2025
Q4 		$433M Buy
5,450,222
+515,063
+10% +$43.5M 0.02% 564
2025
Q3 		$326M Buy
4,935,159
+1,689,449
+52% +$101M 0.02% 662
2025
Q2 		$172M Buy
3,245,710
+21,329
+0.7% +$1M 0.01% 883
2025
Q1 		$160M Buy
3,224,381
+1,358,133
+73% +$75.5M 0.01% 898
2024
Q4 		$118M Buy
1,866,248
+1,459,434
+359% +$84.4M 0.01% 1046
2024
Q3 		$20M Sell
406,814
-6,283
-2% -$295K ﹤0.01% 1705
2024
Q2 		$18.6M Buy
413,097
+9,565
+2% +$325K ﹤0.01% 1678
2024
Q1 		$25.1M Buy
403,532
+186,120
+86% +$12.1M ﹤0.01% 1570
2023
Q4 		$12.6M Sell
217,412
-88,021
-29% -$4.51M ﹤0.01% 1778
2023
Q3 		$14.3M Sell
305,433
-17,621
-5% -$881K ﹤0.01% 1711
2023
Q2 		$14.3M Buy
323,054
+171,355
+113% +$6.08M ﹤0.01% 1756
2023
Q1 		$3.21M Sell
151,699
-41,539
-21% -$925K ﹤0.01% 2236
2022
Q4 		$3.84M Buy
193,238
+180,085
+1,369% +$8.97M ﹤0.01% 2190
2022
Q3 		$647K Sell
13,153
-36
-0.3% -$1.7K ﹤0.01% 2707
2022
Q2 		$669K Sell
13,189
-56
-0.4% -$2.48K ﹤0.01% 2767
2022
Q1 		$551K Sell
13,245
-49,663
-79% -$2.6M ﹤0.01% 2957
2021
Q4 		$5.49M Sell
62,908
-202
-0.3% -$19.8K ﹤0.01% 2341
2021
Q3 		$7.65M Sell
63,110
-33,750
-35% -$4.61M ﹤0.01% 2225
2021
Q2 		$18.8M Buy
96,860
+3,877
+4% +$1.27M ﹤0.01% 1867
2021
Q1 		$36.1M Buy
+92,983
New +$41.5M ﹤0.01% 1536

Other funds holding IRON

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return